Global Gene Therapy Market 2018-2022 - Growing Research in Gene Therapy for CVDs and Orphan Diseases - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Global Gene Therapy Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.
The Global Gene Therapy Market to grow at a CAGR of 22.42% during the period 2018-2022.
Gene therapy is one of the most recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology and cardiovascular. It is the usage of modified gene injected into the patient’s body primarily through virus as a vector. This transmitted gene reaches the intended site to kill or treat the infected cell, thus curing the disease.
One trend affecting this market is the growing research in gene therapy for CVDs and orphan diseases. The increasing prevalence of CVDs and the urgency to treat the diseases in less time is leading the major companies to move towards more effective therapies, such as gene therapy.
According to the report, one driver influencing this market is the entry of novel molecules during the forecast period. Presently, gene therapy is one of the most advanced treatment methods in the pharmaceutical industry and there is a strong pipeline for the development of gene therapy in the forecast period.
Further, the report states that one challenge affecting this market is the high treatment costs. The competition between standard reference drug and generic drugs is intense as generics have the same therapeutic activity as the reference drug.
Key vendorsBiogen Gilead Novartis Orchard Therapeutics Spark Therapeutics
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 05: MARKET SIZINGMarket definition Market sizing 2017 Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY THERAPY AREASegmentation by therapy area Comparison by therapy area Oncology CNS Ophthalmology Rare diseases Others Market opportunity by therapy area
PART 08: PIPELINE
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPEGeographical segmentation Regional comparison Key leading countries Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDSGrowing research in gene therapy for CVDs and orphan diseases Growing strategic alliances Increasing government initiatives
PART 14: VENDOR LANDSCAPELandscape disruption
PART 15: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors
For more information about this report visit https://www.researchandmarkets.com/research/h7w2dw/global_gene?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180925005840/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/25/2018 10:57 AM/DISC: 09/25/2018 10:57 AM